Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis

Christine Sekaggya-Wiltshire, Kelly E. Dooley

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)615-618
Number of pages4
JournalExpert Opinion on Drug Metabolism and Toxicology
Volume15
Issue number8
DOIs
StatePublished - Aug 3 2019

Keywords

  • Rifamycins
  • pharmacodynamics
  • pharmacokinetics
  • tuberculosis

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this